期刊文献+

大豆异黄酮抗瘤效应及其机制的研究进展 被引量:2

Anti-tumor effects and mechanisms of soy isoflavone
原文传递
导出
摘要 大豆异黄酮(SIF)是具有能与雌激素受体结合、诱导产生弱雌激素样作用的植物化学物质。最近的研究表明,SIF是一种很有潜力的癌症化学预防剂,对乳腺癌、结肠癌和前列腺癌、肺癌等发生具有一定的预防作用。其可能的抗瘤机制包括雌激素和抗雌激素作用、抑制酪氨酸蛋白激酶(TPK)活性、诱导癌细胞凋亡分化及与抗癌药协同作用等。 Soy isoflavone is a kind of chemical materials, which comes from plants, especially soybean, can bind to estrogen receptor and induce ambly-estrogen-like effects. Recent data indicates that soy isoflavone maybe a potential cancer chemopreventive agent, which has shown preventive effects on mammary cancer, colon carcinoma, prostatic carcinoma and lung carcinoma, etc. The possible mechanisms of antitumor effects include estrogen-like and anti-estrogen function, tyrosine protein kinase (TPK) activity inhibition, cancer cell apoptosis and differentiation induction, synergistic effects with other anticancer drugs, and so on.
出处 《国际肿瘤学杂志》 CAS 2007年第7期490-493,共4页 Journal of International Oncology
关键词 异黄酮类 抗肿瘤药 Isoflavones Antineoplastic agents
  • 相关文献

参考文献1

二级参考文献37

  • 1Shutt DA, Cox RI. Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J Endocrinol 1972; 52:299-310. 被引量:1
  • 2Mathieson RA, Kitts WD. Binding of phytooestrogen and estradiol-17beta by cytoplasmic receptors in the pituitary gland and hypothalamus of the ewe. J Endocrinol 1980; 85:317-325. 被引量:1
  • 3Martin PM, Horowitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells.Endocrinology 1978; 103:1860-1867. 被引量:1
  • 4Makela S, I~avis VL, Tally WC, Korkman J, Salo L, Vihko R, Santti R, Korach KS. Dietary estrogens act through estrogen receptormediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ Health Perspect 1994; 102:572-578. 被引量:1
  • 5Thigpen JE, Haseman JK, Saunders H, Locklear J, Caviness G,Grant M, Forsythe D. Dietary factors affecting uterine weights of immatur CD-1 mice used in uterotrophic bioassays. Cancer Detect Prev 2002; 26:381-393. 被引量:1
  • 6FoIman Y, Pope GS. The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other uterovaginotrophic compounds of low potency. J Endocrinol 1966; 34:215-225. 被引量:1
  • 7Polkowski K, Mazurek AP. Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm 2000; 57:135-155. 被引量:1
  • 8Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Effect of genistein on topoisomerase activity and on the growth of [Va112]Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 1988; 157:183-189. 被引量:1
  • 9Tripathi YB, Lim RW, Fernandez-Gallardo S, Kandala JC,Guntaka RV, Shukla SD. Involvement of tyrosine kinase and protein kinase C in platelet-activating-factor-induced c-fos gene expression in A421 cells. Biochem J 1992; 286(Pt 2): 527-533. 被引量:1
  • 10Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itho N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262:5592-5595. 被引量:1

共引文献7

同被引文献10

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部